Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 33471-33480 Newer>

The Motley Fool December 11, 2008 Morgan Housel	The Unmatched Brazenness of Goldman Sachs Goldman Sachs is at it again. It's advising clients to bet against products that it peddled into the market itself.
The Motley Fool December 11, 2008 Dan Caplinger	Find the Best Deal on Dividend Stocks Once you decide that you want to add some dividend stocks or funds to your portfolio, you need to figure out how to do it.
The Motley Fool December 11, 2008 Rich Smith	This Just In: Upgrades and Downgrades Five separate analysts downgrade gaming guru Electronic Arts.
The Motley Fool December 11, 2008 Rick Aristotle Munarriz	5 Reasons Disney Should Buy Electronic Arts A combination of EA's battered share price and Disney's desire to ramp up its gaming presence dovetail nicely.
The Motley Fool December 11, 2008 Anders Bylund	Amazon's Elastic Cloud Stretches to Europe Amazon has extended the reach of its Elastic Computing Cloud overseas.
The Motley Fool December 11, 2008 Rich Smith	Time to Buy TI? Once Texas Instruments resumes its growth trend, we'll all look back on today's 6.5 times valuation, and regret not buying at these dirt cheap prices.
The Motley Fool December 11, 2008 Dan Caplinger	The Smart Strategy for Today's Markets You can't ask for a better time than now to buy stocks. The biggest danger from the downturn isn't the loss you've seen in your net worth. Rather, it's the prospect that you might give up on investing entirely.
The Motley Fool December 11, 2008 Brian Orelli	A Painful Letter from the FDA The FDA smacked down King Pharmaceuticals and Pain Therapeutics with a complete response letter for their application to market Remoxy, an abuse-resistant controlled-release form of oxycodone.
The Motley Fool December 11, 2008 Anders Bylund	The Best CEO I Know Today, I'd like to shine a special spotlight on perhaps the greatest business leader on my radar: Netflix CEO Reed Hastings.
The Motley Fool December 11, 2008 Brian Orelli	Drugmakers Could Lose Their Greatest Weapon Congress is thinking about putting limits on direct-to-consumer advertisements. The pharmaceutical industry trade group makes a preemptive strike.
<Older 33471-33480 Newer> Return to current articles.